QUANTERIX CORP (QTRX) Stock News

USA - Nasdaq - NASDAQ:QTRX - US74766Q1013 - Common Stock

7.41 USD

-0.15 (-1.98%)

Last: 12/15/2025, 8:00:02 PM

7.35 USD

-0.06 (-0.81%)

After Hours: 12/15/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

QTRX Latest News, Press Relases and Analysis

All

Press Releases

26 days ago - By: Quanterix Corporation

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

a month ago - By: Quanterix Corporation

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

a month ago - By: Zacks Investment Research - Mentions: MDT

Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates

a month ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the Third Quarter of 2025

a month ago - By: Benzinga

Earnings Preview For Quanterix

4 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

a month ago - By: Quanterix

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

2 months ago - By: Zacks Investment Research

All You Need to Know About Quanterix (QTRX) Rating Upgrade to Buy

4 months ago - By: Quanterix Corporation

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

4 months ago - By: Zacks Investment Research

Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)

4 months ago - By: Quanterix Corporation

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: Zacks Investment Research - Mentions: CAPR

Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates

4 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the Second Quarter of 2025

4 months ago - By: Quanterix Corporation

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

4 months ago - By: Quanterix Corporation

Quanterix Announces Cooperation Agreement with Kent Lake Capital

5 months ago - By: Quanterix Corporation

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

5 months ago - By: Quanterix Corporation

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Quanterix Corporation

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

6 months ago - By: Quanterix Corporation

Quanterix Expands Reach with IVD and Large Reference Labs

6 months ago - By: Quanterix Corporation

Quanterix to Present at Goldman Sachs Global Healthcare Conference

7 months ago - By: Kent Lake PR LLC - Mentions: AKYA

News Image

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

7 months ago - By: Zacks Investment Research - Mentions: MDT

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Quanterix Corporation

Quanterix Releases Financial Results for the First Quarter of 2025

7 months ago - By: Zacks Investment Research - Mentions: PAHC

Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates

7 months ago - By: Quanterix Corporation

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

8 months ago - By: Kent Lake PR LLC

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

8 months ago - By: Quanterix Corporation - Mentions: AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

8 months ago - By: Halper Sadeh LLC - Mentions: BRDG AKYA CKPT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders

8 months ago - By: Kent Lake PR LLC

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders